Literature DB >> 23462729

Value of computed tomography in determining the nature of papillary thyroid microcarcinomas: evaluation of the computed tomographic characteristics.

Zhi-Jiang Han1, Yan-Yan Shu, Xu-Feng Lai, Wen-Hui Chen.   

Abstract

OBJECTIVE: This study was designed to assess the value of computed tomography (CT) in determining the nature of papillary thyroid microcarcinomas (PTMCs).
METHODS: Four hundred fifty-two thyroid CT scan cases with pathological data at our department that were performed from January 2011 to January 2012 were analyzed, of which a total of 87 tumors in 73 cases were confirmed as 0.5-1.0 cm diameter PTMC; the CT images of PTMC were analyzed, suitable window width (W) and window level (L) of PTMC were determined, as well as observation of the density and shape of tumors, tumor boundaries before and after contrast enhancement, thyroid edge interruption, calcification, lymph node metastasis, and complications.
RESULTS: Plain scan W 140-180, L 80-120 and contrast-enhanced scan W 160-200, L 110-150 were conducive to the display of PTMC. Among 87 tumors in this group, aside from 10 tumors and intratumoral calcification that were not shown up, plain CT scans of 77 (88.5%) tumors showed homogeneous low density; 59(67.8%) tumors were irregular shaped; 64 (73.6%) tumors showed plain thyroid scan edge interruption; after contrast enhancement, 65 (74.7%) tumor contours were relatively obscure compared with plain scan, and relative low-density range of the tumors narrowed down; 16 (18.4%) tumors were calcified, of which 15 (93.8%) were fine granular calcifications; lymph node metastasis were found pathologically in 18 (24.7%) cases, of which 8 (44.4%, 8/18) cases were CT findings. Among the 10 (11.4%) tumors that did not show up on CT, 7 were complicated with Hashimoto's thyroiditis, 2 were masked by clavicle artifacts, and 1 was masked by nodular goiter.
CONCLUSION: Plain scan W 140-180, L 80-120 and contrast-enhanced scan W 160-200, L 110-150 were conducive to the display of PTMC. The tumor-shaped irregularity, smaller relative low-density area after contrast enhancement than plain scan, thyroid edge interruption, fine granular calcification, and neck lymph node abnormalities contributed to the diagnosis of PTMC; Hashimoto's thyroiditis, clavicle artifacts, and nodular goiter could mask the tumor, which required adequate attention.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23462729     DOI: 10.1016/j.clinimag.2012.12.005

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  5 in total

1.  Diagnostic accuracy of single-source dual-energy computed tomography and ultrasonography for detection of lateral cervical lymph node metastases of papillary thyroid carcinoma.

Authors:  Lin Li; Sai-Nan Cheng; Yan-Feng Zhao; Xiao-Yi Wang; De-Hong Luo; Yong Wang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma.

Authors:  Tian-Tian Yang; Yong Huang; Xu-Quan Jing; Xiu-Juan Gai; Wen-Wu Li
Journal:  Onco Targets Ther       Date:  2016-10-13       Impact factor: 4.147

3.  Hounsfield Unit Values in ACR TI-RADS 4-5 Thyroid Nodules with Coarse Calcifications: An Important Imaging Feature Helpful for Diagnosis.

Authors:  Pei-Ying Wei; Nian-Dong Jiang; Jing-Jing Xiang; Chen-Ke Xu; Jin-Wang Ding; Hai-Bin Wang; Ding-Cun Luo; Zhi-Jiang Han
Journal:  Cancer Manag Res       Date:  2020-04-22       Impact factor: 3.989

4.  Evaluation of surgical risk and prognosis between thyroid nodules of size <1 and ≥1 cm.

Authors:  Jia-Min Ma; Lin-Feng Wu; Ji-Sheng Hu; Zong-Wen Zhu; Guang-Zhou Li; Guo-Qing Li; Bei Sun; Gang Wang
Journal:  Gland Surg       Date:  2019-12

5.  Cascade and Fusion of Multitask Convolutional Neural Networks for Detection of Thyroid Nodules in Contrast-Enhanced CT.

Authors:  Zuopeng Zhao; Chen Ye; Yanjun Hu; Ceng Li; Xiaofeng Li
Journal:  Comput Intell Neurosci       Date:  2019-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.